Brought to you by 
Northstar Neuroscience completes $113.9mm IPO
Mar 2006
Executive Summary
Northstar Neuroscience (developing an implantable stimulation system to help patients recover from stroke) has sold 8.17mm common shares (including the overallotment) at $15 apiece, netting $113.9mm. The company had initially anticipated a smaller offering of 6mm shares at $12-14, which would have brought in only $78mm.
Deal Industry
-
Medical Devices
- Implantable Devices
- Radiofrequency Devices
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Northstar Neuroscience completes $113.9mm IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice